Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of GBP 62.85 billion. The enterprise value is 79.34 billion.

Market Cap	62.85B
Enterprise Value	79.34B

Important Dates

The next estimated earnings date is Wednesday, July 16, 2025.

Earnings Date	Jul 16, 2025
Ex-Dividend Date	Jun 10, 2025

Share Statistics

Current Share Class	225.93M
Shares Outstanding	n/a
Shares Change (YoY)	-2.07%
Shares Change (QoQ)	-1.69%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	225.42M

Valuation Ratios

The trailing PE ratio is 13.72 and the forward PE ratio is 11.13.

PE Ratio	13.72
Forward PE	11.13
PS Ratio	0.44
PB Ratio	1.91
P/TBV Ratio	37.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.86, with an EV/FCF ratio of 27.90.

EV / Earnings	17.33
EV / Sales	0.59
EV / EBITDA	10.86
EV / EBIT	11.91
EV / FCF	27.90

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.70.

Current Ratio	1.43
Quick Ratio	1.30
Debt / Equity	0.70
Debt / EBITDA	2.99
Debt / FCF	8.17
Interest Coverage	7.23

Financial Efficiency

Return on equity (ROE) is 14.17% and return on invested capital (ROIC) is 8.17%.

Return on Equity (ROE)	14.17%
Return on Assets (ROA)	4.93%
Return on Invested Capital (ROIC)	8.17%
Return on Capital Employed (ROCE)	11.86%
Revenue Per Employee	1.36M
Profits Per Employee	43,951
Employee Count	104,200
Asset Turnover	1.58
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 1.44 billion in taxes.

Income Tax	1.44B
Effective Tax Rate	23.91%

Stock Price Statistics

The stock price has decreased by -28.45% in the last 52 weeks. The beta is 0.62, so Elevance Health's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-28.45%
50-Day Moving Average	395.74
200-Day Moving Average	418.20
Relative Strength Index (RSI)	47.09
Average Volume (20 Days)	9,554

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.40

Income Statement

In the last 12 months, Elevance Health had revenue of GBP 141.74 billion and earned 4.58 billion in profits. Earnings per share was 19.82.

Revenue	141.74B
Gross Profit	39.31B
Operating Income	7.07B
Pretax Income	6.01B
Net Income	4.58B
EBITDA	7.61B
EBIT	7.07B
Earnings Per Share (EPS)	19.82

Full Income Statement

Balance Sheet

The company has 26.05 billion in cash and 23.22 billion in debt, giving a net cash position of -17.42 billion.

Cash & Cash Equivalents	26.05B
Total Debt	23.22B
Net Cash	-17.42B
Net Cash Per Share	n/a
Equity (Book Value)	32.99B
Book Value Per Share	145.79
Working Capital	14.26B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.75 billion and capital expenditures -907.89 million, giving a free cash flow of 2.84 billion.

Operating Cash Flow	3.75B
Capital Expenditures	-907.89M
Free Cash Flow	2.84B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.74%, with operating and profit margins of 4.99% and 3.23%.

Gross Margin	27.74%
Operating Margin	4.99%
Pretax Margin	4.24%
Profit Margin	3.23%
EBITDA Margin	5.37%
EBIT Margin	4.99%
FCF Margin	2.01%

Dividends & Yields

This stock pays an annual dividend of 5.12, which amounts to a dividend yield of 1.35%.

Dividend Per Share	5.12
Dividend Yield	1.35%
Dividend Growth (YoY)	4.10%
Years of Dividend Growth	7
Payout Ratio	25.60%
Buyback Yield	2.07%
Shareholder Yield	3.41%
Earnings Yield	7.29%
FCF Yield	4.52%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5